Liwei Dong
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
Papers in
-
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 6
- Genomics, phytochemicals, and oxidative stress 5
-
- Cancer, Lipids, and Metabolism 7
- Cancer-related molecular mechanisms research 6
- Co-authors
- Hongyang Wang (41 shared papers)Yexiong Tan (41 shared papers)Yufei Pan (28 shared papers)Tianyi Jiang (27 shared papers)Xiuliang Cui (1 shared paper)Hao Tang (1 shared paper)Wei Chen (1 shared paper)Jiantao Dong (1 shared paper)
- Journals
- Hepatology (6 papers)Cell Death and Disease (4 papers)Cancer Letters (4 papers)Cell Research (4 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Liwei Dong
100 papers receiving 3.2k citations
Liwei Dong's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 584
- Immunology 500
- Infectious Diseases 379
- Molecular Biology 1.4k
- Hepatology 128
Countries citing papers authored by Liwei Dong
This map shows the geographic impact of Liwei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei Dong more than expected).
Fields of papers citing papers by Liwei Dong
This network shows the impact of papers produced by Liwei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei Dong. The network helps show where Liwei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Liwei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune cell profiling of COVID-19 patients in the recovery stageby single-cell sequencing Hit paper breakdown → | 2020 | 533 |
| 2 | 2016 | 127 | |
| 3 | 2007 | 114 | |
| 4 | 2015 | 113 | |
| 5 | 2014 | 103 | |
| 6 | 2013 | 75 | |
| 7 | 2015 | 74 | |
| 8 | 2011 | 67 | |
| 9 | 2022 | 61 | |
| 10 | 2009 | 61 | |
| 11 | 2013 | 61 | |
| 12 | 2011 | 58 | |
| 13 | 2011 | 58 | |
| 14 | 2023 | 55 | |
| 15 | 2016 | 54 | |
| 16 | 2023 | 53 | |
| 17 | 2011 | 52 | |
| 18 | 2013 | 51 | |
| 19 | 2015 | 51 | |
| 20 | 2015 | 50 |
About Liwei Dong
Liwei Dong is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Immunology, having authored 102 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), RNA modifications and cancer (7 papers), Cancer, Lipids, and Metabolism (7 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related molecular mechanisms research (6 papers), Peptidase Inhibition and Analysis (6 papers), Autophagy in Disease and Therapy (5 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). The work is most often cited by research in Cancer Research (584 citations), Immunology (500 citations), Infectious Diseases (379 citations), Molecular Biology (1.4k citations) and Hepatology (128 citations). Liwei Dong has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Hongyang Wang, Yexiong Tan, Yufei Pan, Tianyi Jiang, Xiuliang Cui, Hao Tang, Wei Chen, Jiantao Dong, Wen Wen and Depeng Wang. Their work appears in journals such as Hepatology, Cell Death and Disease, Cancer Letters, Cell Research and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.